A profusion of circulating candidate biomarkers in heart failure is currently being
investigated. Although all will advance our insight into the pathophysiology of heart failure …

Cardiac biomarkers are very important in diagnosis, risk stratification, and management of
patients with heart failure. Although not meeting all criteria for an ideal biomarker, natriuretic …

Heart failure is a complex disease in which a careful clinical examination and the
measurement of cardiac function may not always be sufficient for making a correct …

Heart failure is a prevalent and costly disease, and its management with polypharmacy is
complex. Commonly available biomarkers primarily help to 1) establish or refute the …

Biomarkers play an important role in heart failure, but there remain unanswered questions
regarding optimization of their use. They should be used as an adjunct to, not replacement …

Heart failure is a clinical condition with complex pathophysiology that involves many
different processes. Diagnosis is often difficult in patients presenting for the first time with …

The role of biomarkers is increasingly recognized in heart failure (HF) management, for
diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides …

New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

The management of heart failure patients (diagnosis, treatment monitoring, assessment of
prognosis) crucially depends on the accuracy of the tools used for patient evaluation. While …

Cardiac biomarkers play an important role in and provide better pathophysiological
understanding of chronic heart failure (CHF). Natriuretic peptides, especially B-type …